USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Celsia Technologies Taiwan, Inc.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact).

RSS updates for this company

The verdict

According to USPTO PatentsView, Celsia ranks #45,541 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#45,541
of 49,997 US assignees by volume
6th percentile
by Innovation Score (19.4/100)
8.8
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45541 · Foreign Corporation #45,541 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,541/49,997
  • PHOTO-FINISH Cellact Pharma
  • CPC-NARROW F28D · 5 areas
  • INNOV-LOW 19.4/100
  • CLAIMS-PAR 8.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cellact Pharma GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Celsia’s 19.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Celsia

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Celsia's Innovation Score is 19.4/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Celsia?

Each dot is one of Celsia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Celsia’s own 8.8 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Celsia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 010203040 Granted patents (volume) Avg claims / patent Cellact Pharma GMBH - 5, 10.4Cellact PharmaCellblock FCS, LLC - 5, 16.8Cellblock FCSCellomat Israel Ltd. - 5, 31.4Cellomat IsraelCelonova Stent, Inc. - 5, 18.4Celonova StentCENDRES+METAUX SA - 5, 14.8Cendres+MetauxCenshare GMBH - 5, 19.8CenshareCentenary Institute OF Cancer Medicine AND Cell Biology - 5, 10Centenary Institu…Centicare Corporation - 5, 4.8CenticareCelsia Technologies Taiwan, Inc. - 5, 8.8Celsia Taiwan
Celsia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Celsia's grants concentrate

Celsia Technologies Taiwan, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Celsia sits between Cellact Pharma GMBH and Centicare Corporation.

Who files at Celsia's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Celsia holds 5 patents at rank #45,475, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Celsia

By rank, the assignees closest to #45,475 in granted patent volume.

Leaders in F28D (Heat-exchange Apparatus)

Other assignees with the most granted patents in Celsia's primary technology class.

Celsia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 6th percentile higher than 6% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2017202020212025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Celsia Technologies Taiwan, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 20.0%
2020 1 20.0%
2021 2 40.0%
2025partial year 1 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Celsia Technologies Taiwan, Inc.'s patent record in context - here's where to go next.

  • Celsia Technologies Taiwan, Inc.'s lead technology class is F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact), 80% of its portfolio - see every assignee active in that class. Explore F28D
  • Ranked #45,541 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Celsia Technologies Taiwan, Inc. against Cellact Pharma GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 19.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.